For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION), according to a research letter published online July 31 in JAMA Ophthalmology.
This article was originally published on MedicalXpress.com